Matthew D Zimmerman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Matthew D Zimmerman

Showing results (61-70 of 84) with videos related to

Pageof 9

Sort By:

Bioorganic & Medicinal Chemistry Letters|August 30, 2024

Enhancing the therapeutic window for Spectinamide anti-tuberculosis Agents: Synthesis, Evaluation, and activation of phosphate prodrug 3408Jiuyu Liu, Pradeep B Lukka, Victoria A Ektnitphong, et al.

Antimicrobial Agents and Chemotherapy|May 6, 2015

A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosetsLaura E Via, Kathleen England, Danielle M Weiner, et al.

Nature Microbiology|May 31, 2022

CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosisShuqi Li, Nicholas C Poulton, Jesseon S Chang, et al.

ACS Infectious Diseases|May 27, 2016

Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ MiceScott M Irwin, Brendan Prideaux, Edward R Lyon, et al.

Science Translational Medicine|December 22, 2021

Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibioticsJay-Hyun Jo, Catriona P Harkins, Nicole H Schwardt, et al.

Plos Pathogens|April 22, 2026

Physiologic recovery of Mycobacterium tuberculosis from drug injury: A molecular study of post antibiotic effect in vitro and in vivoJo Hendrix, Reem Al Mubarak, Matthew J Reichlen, et al.

Journal of Medicinal Chemistry|May 26, 2023

Investigation into the Mechanism of Action of the Tuberculosis Drug Candidate SQ109 and Its Metabolites and Analogues in MycobacteriaSatish R Malwal, Ben Mazurek, Jihee Ko, et al.

Antimicrobial Agents and Chemotherapy|October 4, 2023

Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis modelMichelle E Ramey, Firat Kaya, Allison A Bauman, et al.

Frontiers in Immunology|June 2, 2020

Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and MacaquesCaylin G Winchell, Bibhuti B Mishra, Jia Yao Phuah, et al.

Antimicrobial Agents and Chemotherapy|August 11, 2023

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responsesNicholas D Walter, Jackie P Ernest, Christian Dide-Agossou, et al.

Pageof 9

Search research articles

Showing results (61-70 of 84) with videos related to

Sort By:

Pageof 9

Bioorganic & Medicinal Chemistry Letters|August 30, 2024

Enhancing the therapeutic window for Spectinamide anti-tuberculosis Agents: Synthesis, Evaluation, and activation of phosphate prodrug 3408Jiuyu Liu, Pradeep B Lukka, Victoria A Ektnitphong, et al.

Antimicrobial Agents and Chemotherapy|May 6, 2015

A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosetsLaura E Via, Kathleen England, Danielle M Weiner, et al.

Nature Microbiology|May 31, 2022

CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosisShuqi Li, Nicholas C Poulton, Jesseon S Chang, et al.

ACS Infectious Diseases|May 27, 2016

Science Translational Medicine|December 22, 2021

Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibioticsJay-Hyun Jo, Catriona P Harkins, Nicole H Schwardt, et al.

Plos Pathogens|April 22, 2026

Physiologic recovery of Mycobacterium tuberculosis from drug injury: A molecular study of post antibiotic effect in vitro and in vivoJo Hendrix, Reem Al Mubarak, Matthew J Reichlen, et al.

Journal of Medicinal Chemistry|May 26, 2023

Investigation into the Mechanism of Action of the Tuberculosis Drug Candidate SQ109 and Its Metabolites and Analogues in MycobacteriaSatish R Malwal, Ben Mazurek, Jihee Ko, et al.

Antimicrobial Agents and Chemotherapy|October 4, 2023

Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis modelMichelle E Ramey, Firat Kaya, Allison A Bauman, et al.

Frontiers in Immunology|June 2, 2020

Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and MacaquesCaylin G Winchell, Bibhuti B Mishra, Jia Yao Phuah, et al.

Antimicrobial Agents and Chemotherapy|August 11, 2023

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responsesNicholas D Walter, Jackie P Ernest, Christian Dide-Agossou, et al.

Pageof 9